After reading this note you will be able to describe the clinical presentation, perform a focused examination, interpret the key investigations and outline the immediate and definitive management of uncomplicated and complicated UTI/pyelonephritis in Kenyan patients. Always verify drug choices, doses and local protocols against the Kenya MoH guideline and your hospital formulary.
Definition
- Urinary tract infection (UTI): microbial invasion of any part of the urinary system (urethra, bladder, ureters, renal pelvis) with accompanying host inflammatory response.
- Acute pyelonephritis: infection that has ascended to involve the renal parenchyma and pelvis, producing systemic signs of infection and renal inflammation.
Anatomy and physiology you need
| Structure | Relevance to infection |
|---|---|
| Urethra (short in females) | Easy bacterial entry; catheter trauma predisposes |
| Bladder (distensible, mucosal glycosaminoglycan layer) | Stasis or mucosal damage facilitates colonisation |
| Vesicoureteric junction (VUJ) | Antireflux mechanism; obstruction or reflux ↑ risk |
| Renal pelvis & calyces | Site of bacterial proliferation in pyelonephritis |
| Renal interstitium & tubules | Inflammation can impair concentrating ability |
| Autonomic innervation | Pain signals (flank tenderness) arise from renal capsule |
Causes and risk factors
| Category | Specific factors in Kenya |
|---|---|
| Sex‑related | Female sex, recent intercourse, contraceptive diaphragm |
| Anatomical/functional | Pregnancy, urinary obstruction (stones, BPH), neurogenic bladder, VUR |
| Procedural | Catheterisation, cystoscopy, recent surgery, obstetric delivery |
| Systemic illnesses | HIV infection, diabetes mellitus, sickle‑cell disease, TB (genitourinary TB), malaria (hemolysis → urinary stasis), rheumatic fever with valvular disease causing renal hypoperfusion |
| Immunosuppression | Corticosteroids, chemotherapy, transplant immunosuppression |
| Behavioural | Inadequate perineal hygiene, delayed voiding, high fluid loss (e.g., hot climate, diarrhoea) |
| Microbial | Escherichia coli (most common), Klebsiella, Proteus, Enterococcus, Staphylococcus saprophyticus, Pseudomonas (catheter‑associated), Candida (immunocompromised) |
Pathophysiology
- Colonisation of peri‑urethral area →
- Ascension of bacteria up urethra → bladder (cystitis) →
- Bladder mucosal invasion → inflammatory exudate, dysuria →
- Overflow or reflux (obstruction, VUR) → bacteria reach renal pelvis →
- Renal parenchymal infection → neutrophil infiltration, tubular damage → systemic inflammatory response (fever, chills) → possible bacteremia.
Clinical features
History – what to ask
| Domain | Key questions | Rationale |
|---|---|---|
| Typical urinary symptoms | Dysuria, frequency, urgency, suprapubic pain, nocturia, hematuria | Direct irritation of the bladder mucosa; helps differentiate lower UTI from pyelonephritis (systemic signs added). |
| Systemic features | Fever, chills, rigors, flank pain, malaise, anorexia, vomiting | Fever and flank pain suggest renal parenchymal involvement (pyelonephritis). |
| Risk‑factor exposure | Recent sexual activity, contraceptive use, recent catheterisation, recent hospitalisation, recent antibiotics, diabetes, HIV status, TB history, sickle‑cell disease, pregnancy, known urinary tract anomalies | These conditions predispose to colonisation, ascending infection or atypical organisms. |
| Previous episodes | Prior UTI, recurrent infections, prior imaging showing stones or obstruction | Recurrence often signals underlying structural problem. |
| Medication & allergies | Current drugs (especially immunosuppressants, antiretrovirals), drug allergies | Guides choice of empiric agents and avoids adverse reactions. |
| Associated tropical illnesses | Recent malaria treatment, rheumatic fever, known TB, sickle‑cell crises | Certain infections (e.g., TB) can produce atypical pyelonephritis; sickle‑cell disease predisposes to papillary necrosis. |
| Pregnancy | Gestational age, obstetric complications | Pregnancy alters urinary stasis and changes antimicrobial safety. |
| Fluid intake & voiding pattern | Daily fluid volume, voiding frequency, any obstruction symptoms (hesitancy, weak stream) | Low fluid intake and obstruction increase infection risk. |
Examination – what to look for and why
| Finding | What it indicates | Why it occurs |
|---|---|---|
| Vital signs (temperature, pulse, blood pressure) | Fever, tachycardia, hypotension | Systemic response to infection; hypotension signals sepsis. |
| Costovertebral angle (CVA) tenderness | Positive CVA tenderness | Inflammation of renal capsule or parenchyma (pyelonephritis). |
| Suprapubic tenderness | Localised bladder pain | Irritation of bladder wall in cystitis. |
| Abdominal exam (distension, masses) | Palpable kidney, flank mass | May indicate obstructing stone or enlarged kidney from infection. |
| Genitourinary inspection | Perineal erythema, discharge, urethral meatus lesions | Possible sexually transmitted infection or external source of bacteria. |
| Neurological assessment (confusion, altered mental status) | Especially in elderly or immunocompromised | Sepsis‑associated encephalopathy; important for severity grading. |
| Skin (pallor, rash) | Signs of systemic infection or drug reaction | Helps differentiate from other febrile illnesses. |
| Peripheral edema | May suggest renal impairment or heart failure | Provides context for renal function assessment. |
Differential diagnosis
| Condition | Points toward it | Distinguishing features |
|---|---|---|
| Acute cystitis | Dysuria, frequency, no fever, normal CVA | Absence of systemic signs, normal renal labs |
| Acute pyelonephritis | Fever, flank pain, CVA tenderness, possible bacteremia | Positive CVA, elevated inflammatory markers, renal imaging changes |
| Renal/urinary calculi | Flank pain colicky, hematuria, possible obstruction | Pain radiates to groin, no fever unless infected stone |
| Tuberculous pyelonephritis | Chronic low‑grade fever, weight loss, TB history | Sterile pyuria, granulomatous changes on imaging |
| Sickle‑cell papillary necrosis | Flank pain, hematuria, sickle‑cell disease | History of crises, imaging shows papillary sloughing |
| Acute prostatitis (men) | Perineal pain, urinary retention, fever | Tender, enlarged prostate on DRE |
| Sexually transmitted urethritis | Discharge, dysuria, recent partners | Positive STI testing, no CVA tenderness |
| Sepsis from non‑urinary source | Fever, hypotension, organ dysfunction, no urinary symptoms | Negative urinalysis, source identified elsewhere |
Investigations
| Test | What it answers | Interpretation |
|---|---|---|
| Urine dipstick (leukocyte esterase, nitrite) | Presence of pyuria & possible Gram‑negative bacteria | Positive → supports infection; negative does not rule out atypical organisms |
| Mid‑stream clean‑catch urine microscopy & culture | Identify organism, quantify colony‑forming units | ≥10⁵ CFU/mL of a single pathogen = significant infection; polymicrobial growth suggests contamination or complicated source |
| Blood cultures (2 sets) | Detect bacteremia, guide systemic therapy | Positive → indicates severe infection, need for IV antibiotics |
| Full blood count | Leukocytosis, anemia | Elevated WBC supports infection; anemia may suggest chronic disease or TB |
| Serum creatinine & eGFR | Baseline renal function, drug dosing safety | Rising creatinine indicates renal involvement or drug nephrotoxicity |
| C‑reactive protein / ESR | Inflammatory burden | High levels correlate with severity, useful for monitoring |
| Ultrasound kidney‑ureter‑bladder (KUB) | Obstruction, stones, hydronephrosis, abscess | Detects structural causes; hydronephrosis suggests obstruction needing relief |
| CT abdomen/pelvis (contrast if not contraindicated) | Detailed anatomy, abscess, emphysematous changes | Gold standard for complicated pyelonephritis or gas‑forming organisms |
| HIV test (if status unknown) | Immunosuppression risk | Positive → higher risk of atypical pathogens, influences prophylaxis |
| TB urine PCR or culture (if suspicion) | Mycobacterial infection | Positive → treat as TB‑related renal disease |
Diagnosis and severity
Diagnostic criteria
- Uncomplicated lower UTI – Typical urinary symptoms plus positive dip‑stick or urine culture without systemic signs, normal renal function, and no structural abnormality.
- Acute uncomplicated pyelonephritis – Fever ≥38 °C, flank pain/CVA tenderness, urinary symptoms plus pyuria and a positive urine culture, with normal or mildly impaired renal function.
- Complicated UTI / Pyelonephritis – Any of the above plus one or more of: pregnancy, diabetes, immunosuppression (HIV, steroids), urinary obstruction, renal stones, structural anomaly, or infection with resistant/atypical organisms.
Severity grading (adapted for Kenyan setting)
| Severity | Clinical hallmarks | Management implication |
|---|---|---|
| Mild | Fever <39 °C, stable vitals, no vomiting, normal mental status, eGFR >60 mL/min/1.73 m² | Oral antibiotics, outpatient follow‑up if reliable |
| Moderate | Fever ≥39 °C, vomiting, mild dehydration, eGFR 30‑60 mL/min/1.73 m², no organ dysfunction | IV antibiotics, inpatient observation, fluid resuscitation |
| Severe / Septic | Hypotension, tachycardia, altered mental status, eGFR <30 mL/min/1.73 m², positive blood cultures, evidence of abscess or emphysematous change | ICU‑level care, broad‑spectrum IV antibiotics, aggressive fluid resuscitation, possible drainage |
Key points for the student
- Always correlate laboratory data with the clinical picture; a sterile urine culture does not exclude infection in immunocompromised patients (e.g., HIV, TB).
- In pregnant women, any febrile urinary illness is treated as pyelonephritis until proven otherwise.
- Presence of obstruction on imaging upgrades the case to “complicated” and mandates prompt urological intervention.
- Monitor renal function daily in moderate/severe cases; rising creatinine may signal obstructive component or drug toxicity.
- Re‑culture urine 48‑72 h after starting therapy if the patient is not improving; persistent bacteriuria suggests resistant organism or inadequate source control.
By systematically gathering the targeted history, performing a focused exam, and interpreting the concise set of investigations, the clinician can accurately classify the infection, decide on the level of care, and initiate appropriate antimicrobial therapy while anticipating and preventing complications.
Management
Immediate stabilisation
- Airway, Breathing, Circulation – give supplemental O₂ if SpO₂ < 94 %; establish IV access; give isotonic crystalloid bolus for hypotension or signs of sepsis.
- Sepsis bundle – obtain blood cultures before antibiotics, give broad‑spectrum IV antibiotics within the first hour, monitor lactate, and reassess perfusion (urine output ≥ 0.5 mL/kg/h).
Definitive antimicrobial therapy
| Clinical scenario | First‑line IV class* | Oral step‑down (if stable) | Rationale |
|---|---|---|---|
| Uncomplicated cystitis in non‑pregnant adult | Fluoroquinolone (e.g., ciprofloxacin) | Fluoroquinolone PO | Excellent urinary penetration, low resistance in most Kenyan isolates. |
| Complicated UTI / pyelonephritis | Third‑generation cephalosporin (e.g., ceftriaxone) or carbapenem if ESBL risk | Trimethoprim‑sulfamethoxazole or nitro‑furantoin (if susceptible) | Cephalosporin covers most Gram‑negatives; carbapenem reserved for proven ESBL. |
| Pregnant woman | IV ampicillin + gentamicin (or oral amoxicillin) | Continue oral amoxicillin | Safe for fetus, covers common uropathogens. |
| HIV‑positive with CD4 < 200 cells/µL | IV cefepime ± vancomycin (if MRSA risk) | Switch to oral fluoroquinolone when stable | Broader Gram‑negative coverage; consider opportunistic pathogens. |
*Choose agents based on local antibiogram; avoid fluoroquinolones in patients with QT prolongation or tendon disease.
Adjuncts
- Analgesia – paracetamol or NSAID (if renal function permits).
- Hydration – encourage oral fluid intake ≥ 2 L/day; consider bladder irrigation only for obstructive stones.
Monitoring
- Vital signs q1‑2 h until afebrile, then q4 h.
- Urine output hourly; catheterize only if retention.
- Repeat blood/urine cultures 48‑72 h if no clinical improvement.
- Renal function (creatinine, electrolytes) daily while on nephrotoxic agents.
Safety / Contra‑indications
- Avoid aminoglycosides in pre‑existing renal impairment or when serum creatinine rises > 1.5 × baseline.
- Fluoroquinolones contraindicated in pregnancy, known tendon disorders, or severe QT prolongation.
- Nitro‑furantoin avoided in GFR < 30 mL/min or late pregnancy.
- Ensure allergy history; if β‑lactam allergy, use fluoroquinolone or carbapenem with desensitisation if needed.
Complications and prognosis
- Acute complications – renal abscess, emphysematous pyelonephritis, septic shock, acute kidney injury.
- Chronic sequelae – renal scarring, hypertension, chronic kidney disease, recurrent infections.
- Pregnancy – pre‑term labour, low birth weight, pyelonephritis in mother.
- Prognosis – excellent with timely appropriate antibiotics; mortality rises markedly with delayed therapy, ESBL infection, or severe sepsis.
High‑yield exam points
- Look‑alike conditions: differentiate pyelonephritis from renal colic (flank pain + hematuria, no systemic signs) and from acute interstitial nephritis (eosinophilia, rash, recent drug).
- Common wrong first step: prescribing oral antibiotics without obtaining cultures in a febrile patient with suspected pyelonephritis.
- Bedside examiner questions:
- “What are the three cardinal signs of pyelonephritis on examination?” (Costovertebral angle tenderness, fever, urinary symptoms).
- “Why do you obtain a mid‑stream clean‑catch urine sample before starting antibiotics?” (To guide therapy and avoid contamination).
- “Explain the rationale for switching from IV to oral therapy.” (Clinical stability, ability to tolerate PO, and comparable bioavailability).
Clinical case
Case: A 28‑year‑old woman, 10 weeks pregnant, presents with dysuria, suprapubic pain, and fever = 38.7 °C for 24 h. UA shows leukocyte esterase +, nitrites +, and numerous WBCs. No flank tenderness.
Questions
- What is the most appropriate initial management?
Answer: Obtain a clean‑catch urine sample for culture, start IV ampicillin + gentamicin after blood cultures, give IV fluids, and monitor vitals.
- **If the urine culture grows E. coli susceptible to ampicillin, how would you modify therapy?**
Answer: De‑escalate to IV ampicillin alone, then step down to oral amoxicillin once afebrile and able to tolerate PO.
- What follow‑up is required after discharge?
Answer: Repeat urine culture 1 week later, ensure symptom resolution, and schedule a renal ultrasound if recurrent infections occur.
Practice questions
Question 1
A 65‑year‑old man with diabetes presents with fever, chills, left flank pain, and dysuria. His BP is 92/58 mmHg, pulse 118 bpm, and urine dipstick is positive for leukocytes and nitrites. What is the next best step?
A. Oral nitro‑furantoin
B. Immediate IV ceftriaxone after blood cultures
C. CT abdomen without contrast
D. Foley catheter insertion
Answer: B. Immediate IV ceftriaxone after blood cultures
Explanation: Septic presentation with suspected pyelonephritis requires prompt broad‑spectrum IV antibiotics and cultures; oral agents are inadequate.
Question 2
A 22‑year‑old woman presents with dysuria, frequency, and low‑grade fever. UA shows pyuria but no nitrites. Which finding would most strongly suggest acute interstitial nephritis rather than uncomplicated cystitis?
A. Bilateral flank tenderness
B. Eosinophiluria on microscopy
C. Positive leukocyte esterase
D. Cloudy urine
Answer: B. Eosinophiluria on microscopy
Explanation: Eosinophils in urine are characteristic of drug‑induced interstitial nephritis.
Question 3
A pregnant woman at 30 weeks gestation has a confirmed E. coli UTI. Which oral agent is safest for step‑down therapy?
A. Ciprofloxacin
B. Nitro‑furantoin
C. Trimethoprim‑sulfamethoxazole
D. Fosfomycin
Answer: B. Nitro‑furantoin
Explanation: Nitro‑furantoin is considered safe in pregnancy (except near term) and achieves high urinary concentrations.
Question 4
A patient with known HIV (CD4 = 150 cells/µL) develops pyelonephritis. Which additional organism should be considered when choosing empiric therapy?
A. Staphylococcus saprophyticus
B. Pseudomonas aeruginosa
C. Candida albicans
D. Klebsiella pneumoniae
Answer: B. Pseudomonas aeruginosa
Explanation: Immunocompromised patients have higher risk of infection with resistant Gram‑negatives like Pseudomonas.
Question 5
A 45‑year‑old man with recurrent UTIs is found to have a 6 mm distal ureteric stone causing obstruction. Which complication is most likely if the infection is not promptly treated?
A. Emphysematous pyelonephritis
B. Acute tubular necrosis
C. Renal papillary necrosis
D. Bladder carcinoma
Answer: A. Emphysematous pyelonephritis
Explanation: Obstructive uropathy combined with infection predisposes to gas‑forming organisms and emphysematous change.
Drafted with AI assistance from standard references and reviewed for structure. Check details against your lecture notes and the Kenya MoH guideline.